Saturday 17 October 2026
Export GRFS’s income statement to Excel — free account
Grifols, S.A.
GRFS Healthcare Drug Manufacturers General
Grifols, S.A.’s revenue for fiscal 2025 (year ended December 2025) was $8.5 billion, up 9.07% from fiscal 2024. In the quarter to June 2026, revenue grew 5.76%, EPS grew 466.9%, free cash flow grew 300.5% and total debt was flat, each against the same quarter a year earlier. Revenue growth for three consecutive years, operating cash flow growth for three.
7.64
0.10
+1.33%
Follow GRFS
| Dec '19 | Jan '20 | Dec '20 | Jan '21 | Dec '21 | Jan '22 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
5 | — | 4 | — | 4 | — | 3 | 7 | 8 | 5 |
P/E ratio |
20.33 | 20.60 | 17.64 | 18.13 | 19.76 | 20.49 | 24.97 | 55.25 | 20.88 | 10.35 |
Altman Z-Score |
2.19 | — | 1.89 | — | 1.13 | — | 1.10 | 1.28 | 1.22 | 1.38 |
P/S ratio |
2.92 | 2.96 | 2.04 | 2.10 | 0.39 | 0.40 | 0.24 | 0.00 | 0.75 | 0.75 |
Altman Z″-Score (non-manufacturers) |
3.76 | — | 2.99 | — | 2.28 | — | 2.44 | 2.83 | 2.82 | 2.86 |
P/FCF ratio |
39.35 | 39.87 | 20.66 | 21.23 | 5.73 | 5.94 | 272.22 | 0.00 | 18.29 | 9.85 |
Beneish M-Score |
(2.32) | — | (2.43) | — | (2.53) | — | (2.08) | (2.51) | (2.49) | (2.59) |
P/Operating CF |
61.09 | 61.90 | 38.06 | 39.11 | 9.50 | 9.85 | (59.09) | 0.00 | 16.66 | 13.70 |
Dividend Safety Score |
— | — | — | — | — | — | — | — | — | 54 |
P/B ratio |
2.97 | 3.01 | 2.00 | 2.06 | 0.42 | 0.43 | 0.34 | 0.00 | 0.94 | 0.74 |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EV/Sales |
3.87 | 3.91 | 3.31 | 3.37 | 1.72 | 1.74 | 1.27 | 1.34 | 2.10 | 1.91 |
EV/EBITDA |
14.66 | 14.81 | 13.39 | 13.62 | 9.24 | 9.32 | 7.98 | 7.94 | 10.44 | 8.51 |
EV/Operating CF |
22.71 | 22.94 | 15.70 | 15.97 | 10.12 | 10.20 | 17.00 | 90.08 | 23.54 | 13.76 |
EV/FCF |
52.13 | 52.66 | 33.44 | 34.01 | 25.33 | 25.54 | 1,462.80 | (59.21) | 51.23 | 25.24 |
Quick Ratio |
2.14 | 0.81 | 0.78 | 0.33 | 0.91 | 0.67 | 0.65 | 0.60 | 0.93 | 0.80 |
Current Ratio |
3.92 | 2.37 | 2.37 | 1.59 | 1.59 | 2.38 | 2.38 | 2.79 | 2.66 | 2.51 |
Net Debt/EBITDA |
3.30 | 4.88 | 4.88 | 9.45 | 7.88 | 8.41 | 8.38 | 8.37 | 5.49 | 5.19 |
Debt/Assets |
46.38% | 45.25% | 46.00% | 48.28% | 53.07% | 45.01% | 49.95% | 51.57% | 47.50% | 48.92% |
Debt/Equity |
1.05 | 1.35 | 1.05 | 1.69 | 1.40 | 1.59 | 1.27 | 1.39 | 1.18 | 1.27 |
Asset Turnover |
0.36 | 0.00 | 0.35 | 0.00 | 0.29 | 0.00 | 0.28 | 0.31 | 0.34 | 0.37 |
Operating CF/Net income |
0.91 | 1.81 | 1.80 | 3.22 | 3.16 | 0.00 | (0.05) | 3.51 | 5.75 | 2.60 |
Capex/Depreciation |
(1.35) | 0.00 | (1.13) | 0.00 | (0.19) | 0.00 | (0.91) | (0.66) | (0.79) | (0.93) |
Interest Coverage |
3.30 | 243.75 | 3.99 | 94.17 | 2.14 | 40.35 | 1.62 | 1.34 | 1.67 | 1.99 |
| 10.60% | 0.00% | 9.21% | 0.00% | 2.73% | 0.00% | 2.50% | 0.73% | 1.89% | 5.08% | |
| 4.36% | 0.00% | 4.05% | 0.00% | 1.11% | 0.00% | 0.97% | 0.28% | 0.73% | 2.00% | |
ROIC |
6.10% | 0.00% | 4.73% | 0.00% | 2.51% | 0.00% | 2.70% | 2.72% | 4.24% | 4.74% |
Return on Tangible Assets |
10.16% | 12.81% | 14.89% | 3.51% | 4.12% | 3.03% | 3.49% | 0.80% | 2.27% | 6.51% |
Average Days of Receivables |
32.38 | 34.45 | 31.14 | 36.63 | 36.05 | 45.44 | 41.04 | 39.87 | 39.63 | 36.48 |
Research and Development Expense of Revenue |
5.41% | 4.89% | 5.51% | 6.08% | 7.19% | 5.23% | 5.96% | 6.00% | 5.32% | 5.66% |
Selling, General and Administrative Expense of Revenue |
18.49% | 16.76% | 18.46% | 19.40% | 21.52% | 18.09% | 19.63% | 20.73% | 17.40% | 15.72% |
Intangible Assets out of Total Assets |
0.45 | 0.45 | 0.45 | 0.41 | 0.41 | 0.46 | 0.46 | 0.45 | 0.48 | 0.49 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Graham Net Nets |
(0.23) | (0.23) | (0.53) | (0.51) | (2.23) | (2.15) | (4.06) | 0.00 | (1.39) | (1.25) |
Graham Number |
0.00 | 0.00 | 14.72 | 16.72 | 18.58 | 11.72 | 14.16 | 9.83 | 0.00 | 16.03 |
Earnings Yield |
4.92% | 4.86% | 5.67% | 5.52% | 5.06% | 4.88% | 4.00% | 1.81% | 4.79% | 9.66% |
Free Cash Flow Yield |
2.54% | 2.51% | 4.84% | 4.71% | 17.45% | 16.83% | 0.37% | 0.00% | 5.47% | 10.15% |
Revenue per Share |
8.34 | 23.19 | 8.90 | 23.75 | 8.56 | 26.91 | 9.40 | 10.50 | 11.48 | 12.51 |
Operating CF per Share |
0.93 | 4.86 | 1.85 | 2.93 | 1.04 | 0.00 | (0.02) | 0.33 | 1.44 | 1.74 |
Capex per Share |
(0.67) | 0.00 | (0.60) | 0.00 | (0.12) | 0.00 | (0.58) | (0.46) | (0.55) | (0.70) |
Free Cash Flow per Share |
0.26 | 4.86 | 1.25 | 2.93 | 0.92 | 0.00 | (0.59) | (0.13) | 0.88 | 1.04 |
Cash per Share |
4.04 | 2.52 | 0.98 | 3.15 | 4.66 | 2.43 | 0.92 | 1.07 | 1.95 | 1.43 |
Shareholders Equity per Share |
11.19 | 22.18 | 11.20 | 26.59 | 12.70 | 27.20 | 13.11 | 12.69 | 13.70 | 12.64 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
11.19 | 22.18 | 11.20 | 26.59 | 12.70 | 27.20 | 13.11 | 12.69 | 13.70 | 12.64 |
Free Cash Flow |
178.46 | 1,258.43 | 854.50 | 750.62 | 626.92 | 0.00 | (403.68) | (88.43) | 599.81 | 710.52 |
Working Capital |
4,475.10 | 2,056.18 | 2,090.20 | 2,513.58 | 2,408.75 | 3,065.91 | 2,842.34 | 4,476.72 | 3,864.61 | 3,456.43 |
Capital Expenditures |
(458.75) | (407.87) | (413.84) | (388.89) | (79.36) | (427.27) | (392.23) | (313.86) | (376.42) | (474.06) |
Net Current Asset Value |
(3,734.82) | (6,037.08) | (6,156.73) | (7,987.65) | (7,579.48) | (9,698.86) | (8,874.31) | (7,594.13) | (7,651.18) | (7,959.40) |
EV/EBIT |
17.02 | 17.19 | 15.93 | 16.20 | 10.46 | 10.55 | 10.52 | 12.87 | 12.65 | 11.59 |
Capex to Sales |
0.08 | 0.00 | 0.07 | 0.00 | 0.01 | 0.00 | 0.06 | 0.04 | 0.05 | 0.06 |
Price to Operating Income |
12.85 | 13.02 | 9.84 | 10.11 | 2.37 | 2.45 | 1.96 | 0.00 | 4.51 | 4.52 |
| Other line items | ||||||||||
Depreciation/Fixed assets |
0.14 | 0.11 | 0.14 | 0.11 | 0.14 | 0.10 | 0.12 | 0.14 | 0.13 | 0.14 |
Cash ROIC |
0.96% | 8.89% | 5.22% | 3.92% | 2.62% | 0.00% | (1.93%) | (0.41%) | 2.77% | 3.47% |
Accounts Receivable Turnover |
12.23 | 0.00 | 11.88 | 0.00 | 10.64 | 0.00 | 9.87 | 9.53 | 9.60 | 10.03 |
Accounts Payable Turnover |
4.70 | 0.00 | 5.26 | 0.00 | 4.91 | 0.00 | 5.33 | 5.37 | 5.30 | 5.63 |
Inventory Turnover |
1.25 | 0.00 | 1.44 | 0.00 | 1.42 | 0.00 | 1.34 | 1.25 | 1.26 | 1.39 |
Average Days of Payables |
77.02 | 68.49 | 71.18 | 73.61 | 77.29 | 67.38 | 69.71 | 72.43 | 70.42 | 65.80 |
Days of Inventory on Hand |
310.08 | 227.78 | 236.91 | 264.36 | 277.62 | 294.67 | 304.90 | 308.16 | 294.13 | 257.89 |
Average Receivables |
466.81 | 536.44 | 513.50 | 565.77 | 548.45 | 717.22 | 647.45 | 748.86 | 813.30 | 849.05 |
Average Payables |
657.65 | 664.06 | 669.47 | 731.89 | 715.69 | 787.99 | 757.65 | 825.59 | 901.16 | 936.89 |
Average Inventory |
2,462.95 | 2,436.57 | 2,455.45 | 2,538.05 | 2,480.12 | 3,155.27 | 3,023.00 | 3,558.46 | 3,798.18 | 3,790.74 |
Average Assets |
16,071.56 | 17,285.32 | 17,428.05 | 20,645.18 | 20,101.97 | 23,685.16 | 22,721.88 | 22,946.93 | 23,184.13 | 22,732.39 |
Average Common Equity |
6,606.98 | 6,703.29 | 7,671.79 | 7,248.04 | 8,166.59 | 7,811.38 | 8,783.86 | 8,769.75 | 8,971.14 | 8,957.85 |
Columns are period end dates